• 54,085+ CME Conference Registrations Sold
  • 162,256+ Medical Conferences
  • 285 Specialties
  • 11,624 Organizers
  • 158,815 Speakers
  • 159 Countries
  • 4,828 Cities
Duration: CME/CE Points: Faculty:
180 Minutes
CME : 3

MSK COVID-19 and Cancer: Six MSK Physicians Discuss Innovations in Cancer Care during the COVID Crisis course is organized by Memorial Sloan Kettering Cancer Center (MSKCC). This Online CME Conference will be held as a fully web-based course on Aug 11, 2020. 

AMA Credit Designation Statement:
Memorial Sloan Kettering Cancer Center assigns this online CME activity for a maximum of 3.00 AMA PRA Category 1 Credits™. Physicians can claim the credit commensurate based on the extent of their participation in the session.

This CME event will focus on six key areas in which the COVID-19 pandemic has prompted previously unasked questions regarding cancer treatments; including whether cancer surgery is essential or elective; and what effect cancer treatments have on COVID-19 patients. Other topics cover virology, epidemiology and therapeutics; and biotechnology and telemedicine in the quest to continue providing cancer care while keeping pace with an unpredictable, rapidly developing, and widespread disease.

Topics and Objectives:
Lessons Learned in the Critical Care Management of COVID-19 Patients

Neil A. Halpern, MD, MCCM, FCCP, FACP

• Determine how to rapidly approach a strange, new and unpredictable critical illness
• Learn how to accommodate rapidly expanding ICU capacity
• Understand the benefits of a robust ICU informatics infrastructure

Is Cancer Surgery Elective and The Impact of COVID-19 on Surgical Outcomes
Jeffrey Drebin, MD, PhD
• Understand differences between elective and essential surgery and approaches to surgical triage at times of resource limitations
• Recognize the impact of surgical treatment delay on outcomes for different types of solid tumors
• Understand the impact of perioperative COVID-19 on the morbidity and mortality of cancer surgery.

SARS-CoV-2 Virology, Epidemiology and Therapeutics
Tobias M. Hohl, MD, PhD
• Understand the basic mechanisms of viral transmission
• Define the mechanisms for entry of the virus and pathophysiology
• Define therapeutic options and studies for treatment of SARS-CoV-2

COVID-19 Prevention, Health Care Worker and Patient Safety, and Testing
Mini Kamboj, MD
• Discuss available literature on testing and appropriate PPE in the health care environment and outcomes
• Review contact tracing efforts, goals and outcomes
• Discuss available literature on testing for patients and safety

Impact of Cancer Care on COVID-19 Outcomes
Elizabeth V. Robilotti, MD, MPH
• Review available data of COVID-19 severity in the hospitalized cancer patient including number ICU patients
• Define risk factors for the severity of COVID-19 illness
• Define severity of COVID-19 illness in cancer patient based on treatment modality including chemotherapy, targeted treatments, and immune-check point inhibitors

Caring for the COVID-19 Patient Through Cohort Monitoring and Telemedicine and Resuming Treatment for Recovered COVID-19 Patients
Diane Reidy-Lagunes, MD
• Define how to care for the COVID-19 positive patient in the outpatient setting using biotechnology, telemedicine, and a cohort monitoring team approach
• Define consensus guidelines on which patients to test for COVID-19 prior to treatment with antineoplastic therapy
• Review consensus guidelines for resumption of antineoplastic therapy after the recovery of COVID-19 in the cancer patient

Registration is complimentary; please click here for more details

Intended Audience

Oncology, Surgery, Infectious Disease, Biotechnology, Pulmonary Sciences and Critical Care, Quality Management, Hospital safety, Immunotherapies, Epidemiology, Virology, Surgical Critical Care


Activity Fee : Free

Onsite to Virtual Conference

Market your online event to Million plus Healthcare professionals.